{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:28:20Z","timestamp":1738387700875,"version":"3.35.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005317","name":"Kermanshah University Of Medical Sciences, Kermanshah, Iran","doi-asserted-by":"crossref","award":["96259","96259","96259","96259","96259"],"award-info":[{"award-number":["96259","96259","96259","96259","96259"]}],"id":[{"id":"10.13039\/501100005317","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10549-024-07503-7","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T06:02:15Z","timestamp":1729576935000},"page":"397-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Strong association of single nucleotide polymorphisms in BRCA1, ATM, and CHEK2 with breast cancer susceptibility in a sub-population of Iranian women"],"prefix":"10.1007","volume":"209","author":[{"given":"Sepideh","family":"Jahangiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Abdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Soroush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massoud","family":"Houshmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mozaffar","family":"Aznab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"issue":"6","key":"7503_CR1","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.31557\/APJCP.2020.21.6.1585","volume":"21","author":"E Siasi","year":"2020","unstructured":"Siasi E, Solimani M (2020) Associations of single nucleotide polymorphism in miR-146a gene with susceptibility to breast cancer in the Iranian female. Asian Pac J Cancer Prev 21(6):1585","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"7503_CR2","first-page":"243","volume":"9","author":"N Nafissi","year":"2018","unstructured":"Nafissi N, Khayamzadeh M, Zeinali Z, Pazooki D, Hosseini M, Akbari ME (2018) Epidemiology and histopathology of breast cancer in Iran versus other Middle Eastern countries. Middle East J Cancer 9(3):243\u2013251","journal-title":"Middle East J Cancer"},{"key":"7503_CR3","unstructured":"Amani F, Fouladi N, Zakeri A, Tabrizian S, Enteshari-Moghaddam A, Barzegari S (2020) Changing trend of breast cancer in Ardabil\u2019s people by age group, grading, and gender during 2003\u20132016. Middle East J Cancer"},{"issue":"8","key":"7503_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","volume":"21","author":"A Lee","year":"2019","unstructured":"Lee A, Mavaddat N, Wilcox AN, Cunningham AP, Carver T, Hartley S et al (2019) BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors. Genet Med 21(8):1708\u20131718","journal-title":"Genet Med"},{"issue":"11","key":"7503_CR5","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.7150\/ijbs.21635","volume":"13","author":"Y-S Sun","year":"2017","unstructured":"Sun Y-S, Zhao Z, Yang Z-N, Xu F, Lu H-J, Zhu Z-Y et al (2017) Risk factors and preventions of breast cancer. Int J Biol Sci 13(11):1387","journal-title":"Int J Biol Sci"},{"key":"7503_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2147\/CLEP.S206949","volume":"11","author":"N Armstrong","year":"2019","unstructured":"Armstrong N, Ryder S, Forbes C, Ross J, Quek RG (2019) A systematic review of the international prevalence of BRCA mutation in breast cancer. Clin Epidemiol 11:543","journal-title":"Clin Epidemiol"},{"issue":"1","key":"7503_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40659-017-0139-2","volume":"50","author":"L Jara","year":"2017","unstructured":"Jara L, Morales S, De Mayo T, Gonzalez-Hormazabal P, Carrasco V, Godoy R (2017) Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations. Biol Res 50(1):35","journal-title":"Biol Res"},{"issue":"1","key":"7503_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1897-4287-12-10","volume":"12","author":"A B\u0105k","year":"2014","unstructured":"B\u0105k A, Janiszewska H, Junkiert-Czarnecka A, Heise M, Pilarska-Deltow M, Laskowski R et al (2014) A risk of breast cancer in women-carriers of constitutional CHEK2 gene mutations, originating from the North-Central Poland. Hereditary cancer in clinical practice 12(1):1\u20135","journal-title":"Hereditary cancer in clinical practice"},{"issue":"8","key":"7503_CR9","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/cncr.32715","volume":"126","author":"AE Weidner","year":"2020","unstructured":"Weidner AE, Liggin ME, Zuniga BI, Tezak AL, Wiesner GL, Pal T (2020) Breast cancer screening implications of risk modeling among female relatives of ATM and CHEK2 carriers. Cancer 126(8):1651\u20131655","journal-title":"Cancer"},{"issue":"9","key":"7503_CR10","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.7150\/jca.30410","volume":"10","author":"I Gorodetska","year":"2019","unstructured":"Gorodetska I, Kozeretska I, Dubrovska A (2019) BRCA genes: the role in genome stability, cancer stemness and therapy resistance. J Cancer 10(9):2109","journal-title":"J Cancer"},{"key":"7503_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1200\/PO.19.00345","volume":"4","author":"ES Sokol","year":"2020","unstructured":"Sokol ES, Pavlick D, Khiabanian H, Frampton GM, Ross JS, Gregg JP et al (2020) Pan-cancer analysis of BRCA1 and BRCA2 genomic alterations and their association with genomic instability as measured by genome-wide loss of heterozygosity. JCO Precis Oncol 4:442\u2013465","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"7503_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-01301-9","volume":"3","author":"Y Inagaki-Kawata","year":"2020","unstructured":"Inagaki-Kawata Y, Yoshida K, Kawaguchi-Sakita N, Kawashima M, Nishimura T, Senda N et al (2020) Genetic and clinical landscape of breast cancers with germline BRCA1\/2 variants. Commun Biol 3(1):1\u20139","journal-title":"Commun Biol"},{"issue":"7","key":"7503_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/em.22397","volume":"61","author":"MK Mustofa","year":"2020","unstructured":"Mustofa MK, Tanoue Y, Tateishi C, Vaziri C, Tateishi S (2020) Roles of Chk2\/CHEK2 in guarding against environmentally induced DNA damage and replication-stress. Environ Mol Mutagen 61(7):730\u2013735","journal-title":"Environ Mol Mutagen"},{"key":"7503_CR14","doi-asserted-by":"crossref","unstructured":"Weigelt B, Bi R, Kumar R, Blecua P, Mandelker DL, Geyer FC, et al (2018) The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers. J Nat Cancer Inst 110(9):1030\u20131034","DOI":"10.1093\/jnci\/djy028"},{"issue":"8","key":"7503_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/carcin\/bgv079","volume":"36","author":"W-C Chou","year":"2015","unstructured":"Chou W-C, Hu L-Y, Hsiung C-N, Shen C-Y (2015) Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway. Carcinogenesis 36(8):832\u2013840","journal-title":"Carcinogenesis"},{"issue":"11","key":"7503_CR16","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1136\/jmedgenet-2017-104588","volume":"54","author":"B Decker","year":"2017","unstructured":"Decker B, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK et al (2017) Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. J Med Genet 54(11):732\u2013741","journal-title":"J Med Genet"},{"issue":"1","key":"7503_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13058-019-1143-y","volume":"21","author":"C Petridis","year":"2019","unstructured":"Petridis C, Arora I, Shah V, Megalios A, Moss C, Mera A et al (2019) Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years. Breast Cancer Res 21(1):58","journal-title":"Breast Cancer Res"},{"issue":"1","key":"7503_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1134\/S0026893314010026","volume":"48","author":"M Bermisheva","year":"2014","unstructured":"Bermisheva M, Takhirova Z, Bogdanova N, Khusnutdinova E (2014) Frequency of CHEK2 gene mutations in breast cancer patients from Republic of Bashkortostan. Mol Biol 48(1):46\u201351","journal-title":"Mol Biol"},{"issue":"04","key":"7503_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/pme-2017-0088","volume":"15","author":"A Nejati-Azar","year":"2018","unstructured":"Nejati-Azar A, Alivand MR (2018) miRNA 196a2 (rs11614913) & 146a (rs2910164) polymorphisms & breast cancer risk for women in an Iranian population. Pers Med 15(04):279\u2013289","journal-title":"Pers Med"},{"issue":"3","key":"7503_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S Miller","year":"1988","unstructured":"Miller S, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215","journal-title":"Nucleic Acids Res"},{"key":"7503_CR21","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J clinicians 68(6):394\u2013424","DOI":"10.3322\/caac.21492"},{"issue":"6","key":"7503_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.18.01631","volume":"37","author":"PD Beitsch","year":"2019","unstructured":"Beitsch PD, Whitworth PW, Hughes K, Patel R, Rosen B, Compagnoni G et al (2019) Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle? J Clin Oncol 37(6):453","journal-title":"J Clin Oncol"},{"issue":"4","key":"7503_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41436-018-0277-0","volume":"21","author":"SM Rowley","year":"2019","unstructured":"Rowley SM, Mascarenhas L, Devereux L, Li N, Amarasinghe KC, Zethoven M et al (2019) Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility. Genet Med 21(4):913\u2013922","journal-title":"Genet Med"},{"issue":"1","key":"7503_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12885-017-3422-2","volume":"17","author":"EM Grindedal","year":"2017","unstructured":"Grindedal EM, Heramb C, Karsrud I, Ariansen SL, M\u00e6hle L, Undlien DE et al (2017) Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers. BMC Cancer 17(1):438","journal-title":"BMC Cancer"},{"issue":"1","key":"7503_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12575-020-00133-5","volume":"22","author":"F Sadeghi","year":"2020","unstructured":"Sadeghi F, Asgari M, Matloubi M, Ranjbar M, Yousefi NK, Azari T et al (2020) Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biol Proced Online 22(1):1\u201328","journal-title":"Biol Proced Online"},{"issue":"5","key":"7503_CR26","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1002\/jcp.27464","volume":"234","author":"M Mahdavi","year":"2019","unstructured":"Mahdavi M, Nassiri M, Kooshyar MM, Vakili-Azghandi M, Avan A, Sandry R et al (2019) Hereditary breast cancer; genetic penetrance and current status with BRCA. J Cell Physiol 234(5):5741\u20135750","journal-title":"J Cell Physiol"},{"key":"7503_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.mgene.2017.11.002","volume":"15","author":"A Abou-El-Naga","year":"2018","unstructured":"Abou-El-Naga A, Shaban A, Ghazy H, Elsaid A, Elshazli R, Settin A (2018) Frequency of BRCA1 (185delAG and 5382insC) and BRCA2 (6174delT) mutations in Egyptian women with breast cancer compared to healthy controls. Meta Gene 15:35\u201341","journal-title":"Meta Gene"},{"key":"7503_CR28","doi-asserted-by":"crossref","unstructured":"Yang Y, Shu X, Shu X-o, Bolla MK, Kweon S-S, Cai Q, et al. Re-evaluating genetic variants identified in candidate gene studies of breast cancer risk using data from nearly 280,000 women of Asian and European ancestry. EBioMedicine. 2019;48:203\u201311.","DOI":"10.1016\/j.ebiom.2019.09.006"},{"issue":"1","key":"7503_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","volume":"151","author":"D Cragun","year":"2015","unstructured":"Cragun D, Bonner D, Kim J, Akbari M, Narod S, Gomez-Fuego A et al (2015) Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat 151(1):169\u2013176","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"7503_CR30","first-page":"1059","volume":"60","author":"E Levy-Lahad","year":"1997","unstructured":"Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E et al (1997) Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Am J Hum Genet 60(5):1059","journal-title":"Am J Hum Genet"},{"issue":"2","key":"7503_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12282-016-0692-5","volume":"24","author":"S Parvin","year":"2017","unstructured":"Parvin S, Islam MS, Al-Mamun MMA, Islam MS, Ahmed MU, Kabir ER et al (2017) Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population. Breast Cancer 24(2):229\u2013237","journal-title":"Breast Cancer"},{"key":"7503_CR32","unstructured":"Fatahi M, Mojtahedi Z, Karim AN, Taleei AA, Banani SJ, Ghaderi A (2009) Analysis of BRCA1 and BRCA2 mutations in southern Iranian breast cancer patients. Arch Iran Med. 2009 Nov;12(6):584\u20137"},{"issue":"4","key":"7503_CR33","first-page":"210","volume":"5","author":"N Saleh-Gohari","year":"2012","unstructured":"Saleh-Gohari N, Mohammadi-Anaie M, Kalantari-Khandani B (2012) BRCA1 gene mutations in breast cancer patients from Kerman Province, Iran. Iran J Cancer Prev 5(4):210","journal-title":"Iran J Cancer Prev"},{"issue":"4","key":"7503_CR34","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB et al (2011) Rare variants in the ATMgene and risk of breast cancer. Breast Cancer Res 13(4):R73","journal-title":"Breast Cancer Res"},{"key":"7503_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/BCTT.S111394","volume":"9","author":"P Apostolou","year":"2017","unstructured":"Apostolou P, Papasotiriou I (2017) Current perspectives on CHEK2 mutations in breast cancer. Breast Cancer Targets Ther 9:331","journal-title":"Breast Cancer Targets Ther"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07503-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:22:34Z","timestamp":1738354954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7503"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07503-7","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"18 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}